Skip to main content
Clinical Trials/CTRI/2024/06/069376
CTRI/2024/06/069376Not yet recruitingPhase 4

Effect of antenatal Dexamethasone therapy on maternal blood glucose levels and fetal well being - NI

Government medical college and hospital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1 Pregnant women between 26-34 weeks of gestation with threatened preterm labor pains and premature rupture of membranes
  • 2 Antenatal women between 34-39 weeks planned for lower segment cesarean section (LSCS)

Exclusion Criteria

  • 1) Pregnant women with pre-existing diabetes and gestational diabetes mellitus.
  • 2) Pregnant women with fetal growth restriction.
  • 3) Patients who require immediate termination of pregnancy or are in established preterm labor.
  • 4) Pregnant women with evidence of infection, where corticosteroid therapy may lead to flare-up of infection.
  • 5) Patients with chronic kidney disease, and pre-existing adrenal and pancreatic dysfunction.
  • 6) Pregnant women who have received tocolysis with beta-mimetic agents.
  • 7) Multifetal gestation.

Investigators

Sponsor
Government medical college and hospital

Similar Trials